$29.00
In Stock
Adjuvant therapy for early estrogen receptor-positive breast cancer; treatment of locally advanced or metastatic estrogen receptor-positive breast cancer; breast cancer (including in men after castration).
The drug can also be used in other solid tumors that are resistant to standard treatments and in the presence of overexpression of estrogen receptors.
Active ingredient: tamoxifen citrate – 30.4 mg, in terms of tamoxifen – 20.0 mg
Prescription medicine.
